We are pleased to announce that Baker McKenzie has published the FY23 edition of Directors Duties in Australia. This is a timely guide for directors of Australian companies, setting out pivotal issues for directors to consider in the current evolving corporate governance environment. Matters covered in the guide include common law and statutory duties, financial reporting, continuous disclosure, financial assistance, directors’ insurance and indemnities and other topical issues including climate change, cyber security and anti-bribery and corruption.

The new Australian Government promises nearly AUD 1 billion in investments to Medicare and general practices as part of a number of policy commitments to healthcare and aged care initiatives.
On 21 May 2022, Australia elected a new federal government, the Australian Labor Party. As part of its campaign, the newly elected Federal Government committed to a number of healthcare and aged care policy initiatives with a strong focus on improving quality and access to primary care.

This report, the fourth in our Asia Pacific Business Renewal Series, explores how businesses are now fortifying their ESG efforts and pivoting from strategy to action.

This report, the third in our Asia Pacific Business Renewal Series, explores how digital transformation (DX) has become a driving force in business decision making, and how it will shape the business landscape over the decade to come. As companies respond to shifting demand patterns and propel their DX agenda, the conversation turns to areas such as managing emerging risks, creating value from new technologies and aligning DX efforts with business renewal.

The 2021 edition of Duties and Liabilities of Directors of Australian Companies from Baker McKenzie is a timely guide for directors of Australian companies, setting out pivotal issues for directors to consider in the current evolving corporate governance environment. Matters covered in the guide include common law and statutory duties, delegation, financial reporting, continuous disclosure, financial assistance, directors’ insurance and indemnities and other topical issues including climate change, whistleblower protections and anti-bribery and corruption.

The 2021 edition of Duties and Liabilities of Directors of Australian Companies from Baker McKenzie is a timely guide for directors of Australian companies, setting out pivotal issues for directors to consider in the current evolving corporate governance environment. Matters covered in the guide include common law and statutory duties, delegation, financial reporting, continuous disclosure, financial assistance, directors’ insurance and indemnities and other topical issues including climate change, whistleblower protections and anti-bribery and corruption.

The 2021 edition of Duties and Liabilities of Directors of Australian Companies from Baker McKenzie is a timely guide for directors of Australian companies, setting out pivotal issues for directors to consider in the current evolving corporate governance environment.

Countries around the globe are facing unprecedented and rapid change due to the COVID-19 pandemic. The Government Intervention Schemes Guide provides a summary of key government intervention measures across jurisdictions around the globe in relation to: Foreign Investment Restrictions, Debt, Equity, Taxation, Insolvency, EU State Aid Approvals, where relevant.

The 2021 edition of Duties and Liabilities of Directors of Australian Companies from Baker McKenzie is a timely guide for directors of Australian companies, setting out pivotal issues for directors to consider in the current evolving corporate governance environment. Matters covered in the guide include common law and statutory duties, delegation, financial reporting, continuous disclosure, financial assistance, directors’ insurance and indemnities and other topical issues including climate change, whistleblower protections and anti-bribery and corruption.

Click to read Digital healthcare, a globally booming market, has been catalyzed by the events of COVID-19. In Asia Pacific, in particular, a rapidly expanding population, an empowered and tech-savvy middle class and physician shortage has created the perfect conditions for digital health innovation. A new era of digital healthcare…